Benzinga | Nov 5, 2020 04:03PM EST

Xenon Pharmaceuticals Q3 EPS $(0.25) Misses $(0.15) Estimate, Sales $6.55M Miss $10.06M Estimate

Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.15) by 66.67 percent. This is a 24.24 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $6.55 million which missed the analyst consensus estimate of $10.06 million by 34.85 percent. This is a 87.26 percent increase over sales of $3.50 million the same period last year.